{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:33:46Z","timestamp":1794695626437,"version":"4.9.1"},"reference-count":50,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The present study demonstrates that CD4+CD25+ T cells, expanded in peripheral blood of HIV-infected patients receiving highly active antiretroviral therapy (HAART), exhibit phenotypic, molecular, and functional characteristics of regulatory T cells. The majority of peripheral CD4+CD25+ T cells from HIV-infected patients expressed a memory phenotype. They were found to constitutively express transcription factor forkhead box P3 (Foxp3) messengers. CD4+CD25+ T cells weakly proliferated to immobilized anti-CD3 monoclonal antibody (mAb) and addition of soluble anti-CD28 mAb significantly increased proliferation. In contrast to CD4+CD25\u2013 T cells, CD4+CD25+ T cells from HIV-infected patients did not proliferate in response to recall antigens and to p24 protein. The proliferative capacity of CD4 T cells to tuberculin, cytomegalovirus (CMV), and p24 significantly increased following depletion of CD4+CD25+ T cells. Furthermore, addition of increasing numbers of CD4+CD25+ T cells resulted in a dose-dependent inhibition of CD4+CD25\u2013 T-cell proliferation to tuberculin and p24. CD4+CD25+ T cells responded specifically to p24 antigen stimulation by expressing transforming growth factor \u03b2 (TGF-\u03b2) and interleukin 10 (IL-10), thus indicating the presence of p24-specific CD4+ T cells among the CD4+CD25+ T-cell subset. Suppressive activity was not dependent on the secretion of TGF-\u03b2 or IL-10. Taken together, our results suggest that persistence of HIV antigens might trigger the expansion of CD4+CD25+ regulatory T cells, which might induce a tolerance to HIV in vivo.<\/jats:p>","DOI":"10.1182\/blood-2004-01-0365","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T21:38:12Z","timestamp":1090618692000},"page":"3249-3256","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":318,"title":["Human immunodeficiency virus\u2013driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients"],"prefix":"10.1182","volume":"104","author":[{"given":"Laurence","family":"Weiss","sequence":"first","affiliation":[{"name":"From the Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U430 and University Paris V, Paris, France; Department of Immunology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; INSERM U421, Paris and University Paris XII, Cre\u0301teil, France; and Service of Clinical Immunology, Ho\u0302pital Henri Mondor, Cre\u0301teil, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimira","family":"Donkova-Petrini","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U430 and University Paris V, Paris, France; Department of Immunology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; INSERM U421, Paris and University Paris XII, Cre\u0301teil, France; and Service of Clinical Immunology, Ho\u0302pital Henri Mondor, Cre\u0301teil, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Caccavelli","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U430 and University Paris V, Paris, France; Department of Immunology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; INSERM U421, Paris and University Paris XII, Cre\u0301teil, France; and Service of Clinical Immunology, Ho\u0302pital Henri Mondor, Cre\u0301teil, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miche\u0300le","family":"Balbo","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U430 and University Paris V, Paris, France; Department of Immunology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; INSERM U421, Paris and University Paris XII, Cre\u0301teil, France; and Service of Clinical Immunology, Ho\u0302pital Henri Mondor, Cre\u0301teil, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce\u0301dric","family":"Carbonneil","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U430 and University Paris V, Paris, France; Department of Immunology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; INSERM U421, Paris and University Paris XII, Cre\u0301teil, France; and Service of Clinical Immunology, Ho\u0302pital Henri Mondor, Cre\u0301teil, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Levy","sequence":"additional","affiliation":[{"name":"From the Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U430 and University Paris V, Paris, France; Department of Immunology, Ho\u0302pital Europe\u0301en Georges Pompidou, Paris, France; INSERM U421, Paris and University Paris XII, Cre\u0301teil, France; and Service of Clinical Immunology, Ho\u0302pital Henri Mondor, Cre\u0301teil, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222561124900_REF1","doi-asserted-by":"crossref","unstructured":"Rosenberg ES, Billingsley JM, Calliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science.1997;278: 1447-1450.","DOI":"10.1126\/science.278.5342.1447"},{"key":"2020021222561124900_REF2","doi-asserted-by":"crossref","unstructured":"Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science.1997;277: 112-116.","DOI":"10.1126\/science.277.5322.112"},{"key":"2020021222561124900_REF3","doi-asserted-by":"crossref","unstructured":"Pakker NG, Kroon ED, Roos MT, et al. Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy: INCAS Study Group. AIDS.1999;13: 203-212.","DOI":"10.1097\/00002030-199902040-00008"},{"key":"2020021222561124900_REF4","doi-asserted-by":"crossref","unstructured":"Carcelain G, Debre P, Autran B. Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy. Curr Opin Immunol.2001;13: 483-488.","DOI":"10.1016\/S0952-7915(00)00245-4"},{"key":"2020021222561124900_REF5","doi-asserted-by":"crossref","unstructured":"Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic tolerance maintained by activated T cells expressing IL-2 receptor a-chain (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol.1995;155: 1151-1164.","DOI":"10.4049\/jimmunol.155.3.1151"},{"key":"2020021222561124900_REF6","doi-asserted-by":"crossref","unstructured":"Takahashi T, Kuniyasu Y, Toda M, et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic-suppressive state. Int Immunol.1998;10: 1969-1980.","DOI":"10.1093\/intimm\/10.12.1969"},{"key":"2020021222561124900_REF7","doi-asserted-by":"crossref","unstructured":"Levings MK, Sangregorio R, Roncarolo M-G. Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med.2001;193: 1295-1301.","DOI":"10.1084\/jem.193.11.1295"},{"key":"2020021222561124900_REF8","doi-asserted-by":"crossref","unstructured":"Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J Exp Med.2001;193: 1303-1310.","DOI":"10.1084\/jem.193.11.1303"},{"key":"2020021222561124900_REF9","doi-asserted-by":"crossref","unstructured":"Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25+high regulatory cells in human peripheral blood. J Immunol.2001;167: 1245-1253.","DOI":"10.4049\/jimmunol.167.3.1245"},{"key":"2020021222561124900_REF10","doi-asserted-by":"crossref","unstructured":"Piccirillo CA, Shevach EM. Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol.2001;167: 1137-1140.","DOI":"10.4049\/jimmunol.167.3.1137"},{"key":"2020021222561124900_REF11","doi-asserted-by":"crossref","unstructured":"Suri-Payer E, Amar AZ, McHugh RS, Natarajan K, Margulies DH, Shevach EM. Post-thymectomy autoimmune gastritis: fine specificity and pathogenicity of anti-H\/K ATPase-reactive T cells. Eur J Immunol.1999;29: 669-677.","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<669::AID-IMMU669>3.0.CO;2-J"},{"key":"2020021222561124900_REF12","doi-asserted-by":"crossref","unstructured":"Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med.2000;192: 295-302.","DOI":"10.1084\/jem.192.2.295"},{"key":"2020021222561124900_REF13","doi-asserted-by":"crossref","unstructured":"Takahashi T, Tagami T, Yamazaki S, et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med.2000;192: 303-309.","DOI":"10.1084\/jem.192.2.303"},{"key":"2020021222561124900_REF14","doi-asserted-by":"crossref","unstructured":"van Maurik A, Herber M, Wood KJ, Jones ND. CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol.2002;169: 5401-5404.","DOI":"10.4049\/jimmunol.169.10.5401"},{"key":"2020021222561124900_REF15","doi-asserted-by":"crossref","unstructured":"Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol.2003;3: 199-211.","DOI":"10.1038\/nri1027"},{"key":"2020021222561124900_REF16","doi-asserted-by":"crossref","unstructured":"Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN. Human anergic\/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol.2001;31: 1122-1131.","DOI":"10.1002\/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P"},{"key":"2020021222561124900_REF17","doi-asserted-by":"crossref","unstructured":"Roncarolo M-G, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev.2001;182: 68-79.","DOI":"10.1034\/j.1600-065X.2001.1820105.x"},{"key":"2020021222561124900_REF18","doi-asserted-by":"crossref","unstructured":"Weiner HL. Induction and mechanism of action of transforming-growth-factor-beta secreting Th3 regulatory cells. Immunol Rev.2001;182: 207-214.","DOI":"10.1034\/j.1600-065X.2001.1820117.x"},{"key":"2020021222561124900_REF19","doi-asserted-by":"crossref","unstructured":"Levings MK, Sangregorio R, Sartriana C, et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med.2002;196: 1335-1346.","DOI":"10.1084\/jem.20021139"},{"key":"2020021222561124900_REF20","doi-asserted-by":"crossref","unstructured":"Weiss L, Ancuta P, Girard PM, et al. Restoration of normal interleukin-2 production by CD4+ T cells of human immunodeficiency virus-infected patients after 9 months of highly active antiretroviral therapy. J Infect Dis.1999;180: 1057-1063.","DOI":"10.1086\/315025"},{"key":"2020021222561124900_REF21","doi-asserted-by":"crossref","unstructured":"Levy Y, Durier C, Krzysiek R, et al. Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-infection: a randomized control trial. AIDS.2003;17: 343-351.","DOI":"10.1097\/00002030-200302140-00008"},{"key":"2020021222561124900_REF22","doi-asserted-by":"crossref","unstructured":"Miedema F, Petit AJ, Terpstra FG, et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men: HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest.1988;82: 1908-1914.","DOI":"10.1172\/JCI113809"},{"key":"2020021222561124900_REF23","doi-asserted-by":"crossref","unstructured":"Clerici M, Stocks NI, Zajac RA, et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients: independence of CD4+ cell numbers and clinical staging. J Clin Invest.1989; 84: 1892-1899.","DOI":"10.1172\/JCI114376"},{"key":"2020021222561124900_REF24","doi-asserted-by":"crossref","unstructured":"Sereti I, Martinez-Wilson H, Metcalf J, et al. Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4+\/CD25+ T cells. Blood.2002;100: 2159-2167.","DOI":"10.1182\/blood.V100.6.2159"},{"key":"2020021222561124900_REF25","doi-asserted-by":"crossref","unstructured":"Hamann D, Baars PA, Hooibrink B, van Lier RW. Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood.1996;88: 3513-3521.","DOI":"10.1182\/blood.V88.9.3513.bloodjournal8893513"},{"key":"2020021222561124900_REF26","doi-asserted-by":"crossref","unstructured":"Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med.1999;190: 995-1004.","DOI":"10.1084\/jem.190.7.995"},{"key":"2020021222561124900_REF27","doi-asserted-by":"crossref","unstructured":"Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+)T cells with regulatory properties isolated from peripheral blood. J Exp Med.2001;193: 1285-1294.","DOI":"10.1084\/jem.193.11.1285"},{"key":"2020021222561124900_REF28","doi-asserted-by":"crossref","unstructured":"Kalams SA, Buchbinder SP, Rosenberg ES, et al. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol.1999;73: 6715-6720.","DOI":"10.1128\/JVI.73.8.6715-6720.1999"},{"key":"2020021222561124900_REF29","doi-asserted-by":"crossref","unstructured":"Taams LS, Vukmanovic-Stejic M, Smith J, et al. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol.2002;32: 1621-1630.","DOI":"10.1002\/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q"},{"key":"2020021222561124900_REF30","doi-asserted-by":"crossref","unstructured":"Liyanage UK, Moore TT, Joo HS, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol.2002;169: 2756-2761.","DOI":"10.4049\/jimmunol.169.5.2756"},{"key":"2020021222561124900_REF31","doi-asserted-by":"crossref","unstructured":"Jonuleit H, Schlmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells. J Exp Med.2002;196: 255-260.","DOI":"10.1084\/jem.20020394"},{"key":"2020021222561124900_REF32","doi-asserted-by":"crossref","unstructured":"Leng Q, Bentwich Z, Magen E, Kalinkovich A, Borkow G. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention. AIDS.2002;16: 519-529.","DOI":"10.1097\/00002030-200203080-00002"},{"key":"2020021222561124900_REF33","doi-asserted-by":"crossref","unstructured":"Annunziato F, Cosmi L, Liotta F, et al. Phenotype, localization and mechanism of suppression of CD4+CD25+ human thymocytes. J Exp Med.2002;196: 379-387.","DOI":"10.1084\/jem.20020110"},{"key":"2020021222561124900_REF34","doi-asserted-by":"crossref","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol.2003;4: 330-336.","DOI":"10.1038\/ni904"},{"key":"2020021222561124900_REF35","doi-asserted-by":"crossref","unstructured":"Walker MR, Kasprowicz DJ, Gersuk VH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest.2003;112: 1437-1443.","DOI":"10.1172\/JCI19441"},{"key":"2020021222561124900_REF36","doi-asserted-by":"crossref","unstructured":"Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev.2001; 182: 18-32.","DOI":"10.1034\/j.1600-065X.2001.1820102.x"},{"key":"2020021222561124900_REF37","doi-asserted-by":"crossref","unstructured":"Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol.2003;3: 253-257.","DOI":"10.1038\/nri1032"},{"key":"2020021222561124900_REF38","doi-asserted-by":"crossref","unstructured":"Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature.2002;417: 95-98.","DOI":"10.1038\/417095a"},{"key":"2020021222561124900_REF39","doi-asserted-by":"crossref","unstructured":"Dybul M, Mercier G, Belson M, et al. CD40 ligand trimer and IL-12 enhance peripheral blood mononuclear cells and CD4+ T cell proliferation and production of IFN-gamma in response to p24 antigen in HIV-infected individuals: potential contribution of anergy to HIV-specific unresponsiveness. J Immunol.2000;165: 1685-1691.","DOI":"10.4049\/jimmunol.165.3.1685"},{"key":"2020021222561124900_REF40","doi-asserted-by":"crossref","unstructured":"Cohen DE, Walker BD. Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection. Clin Infect Dis.2001;32: 1756-1768.","DOI":"10.1086\/320759"},{"key":"2020021222561124900_REF41","doi-asserted-by":"crossref","unstructured":"Iwashiro M, Messer RJ, Peterson KE, Stromnes IM, Sugie T, Hasenkrug KJ. Immunosuppression by CD4+ regulatory T cells by chronic retroviral infection. Proc Natl Acad Sci U S A.2001;98: 9226-9230.","DOI":"10.1073\/pnas.151174198"},{"key":"2020021222561124900_REF42","doi-asserted-by":"crossref","unstructured":"Yamagiva S, Gray JD, Hashimoto S, Horwitz DA. A role for TGF-b in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol.2001;166: 7282-7289.","DOI":"10.4049\/jimmunol.166.12.7282"},{"key":"2020021222561124900_","doi-asserted-by":"crossref","unstructured":"Taylor PA, Friedman TM, Korngold R, Noelle RJ, Blazar BR. Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40-CD40L costimulatory pathway results in a generation of a potent immune regulatory cell. Blood.2002;99: 4601-4609.","DOI":"10.1182\/blood.V99.12.4601"},{"key":"2020021222561124900_REF44","doi-asserted-by":"crossref","unstructured":"Chirmule N, McCloskey TW, Hu R, Kalyanaraman VS, Pahwa S. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J Immunol.1995;155: 2917-2924.","DOI":"10.4049\/jimmunol.155.2.917"},{"key":"2020021222561124900_REF45","doi-asserted-by":"crossref","unstructured":"McNeil AC, Shupert WL, Iyasere CA, et al. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation. Proc Natl Acad Sci U S A.2001;98: 13878-13883.","DOI":"10.1073\/pnas.251539598"},{"key":"2020021222561124900_REF46","doi-asserted-by":"crossref","unstructured":"Cohen OJ, Kinter A, Fauci AS. Host factors in the pathogenesis of HIV disease. Immunol Rev.1997;159: 31-48.","DOI":"10.1111\/j.1600-065X.1997.tb01005.x"},{"key":"2020021222561124900_REF47","doi-asserted-by":"crossref","unstructured":"Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol.2001; 166: 5530-5539.","DOI":"10.4049\/jimmunol.166.9.5530"},{"key":"2020021222561124900_REF48","doi-asserted-by":"crossref","unstructured":"Garba ML, Pilcher CD, Bingham AL, Eron J, Frelinger JA. HIV antigens can induce TGF-beta(1)-producing immunoregulatory CD8+ T cells. J Immunol.2002;168: 2247-2254.","DOI":"10.4049\/jimmunol.168.5.2247"},{"key":"2020021222561124900_REF49","doi-asserted-by":"crossref","unstructured":"Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4+CD25+ regulatory, contact-dependent T cells induce interleukin 10-producing, contact-idependent type-1-like regulatory T cells. J Exp Med.2002;196: 247-253.","DOI":"10.1084\/jem.20020642"},{"key":"2020021222561124900_REF50","doi-asserted-by":"crossref","unstructured":"Frasca L, Scotta C, Lombardi G, Piccolella E. Human anergic CD4+ T cells can act as suppressor cells by affecting autologous dendritic cell conditioning and survival. J Immunol.2002;168: 1060-1068.","DOI":"10.4049\/jimmunol.168.3.1060"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/10\/3249\/1703323\/zh802204003249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/10\/3249\/1703323\/zh802204003249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T19:16:08Z","timestamp":1705173368000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/10\/3249\/18744\/Human-immunodeficiency-virusdriven-expansion-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,15]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-01-0365","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,15]]}}}